Open for Enrollment Soon
This study will open for enrollment soon. Please contact the study team for more information and check back frequently.

Absorbable Antibacterial Soft Tissue Support in Breast Reconstruction - ARIA - Clinical Trial

What is the Purpose of this Study?

This study lasts about twelve months and includes around twelve to eighteen visits, most of which are regular visits you would have even if you were not in a study. The study is testing a device called the Melodi Matrix. It is a special mesh that has medicine to fight bacteria. The mesh is placed around tissue expanders before they are put into the body. After about nine weeks, the mesh dissolves and is absorbed by the body.

What is the Condition Being Studied?

Women who are undergoing two-stage post- mastectomy breast reconstruction

Who Can Participate in the Study?

People can join this study if they are women who are older than 22 years and are scheduled to have one or both breasts removed. This can include surgery to prevent breast cancer. They must also be planning to have a type of breast reconstruction that uses tissue expanders placed above the chest muscle right after the mastectomy.

Age Group
Adults

What is Involved?

This study is being done to learn if the Melodi Matrix is safe and works well. The Melodi Matrix is a special mesh that has medicine in it to fight bacteria. It is placed around tissue expanders before they are put into the body. The mesh dissolves on its own after several weeks.

Study Details

Full Title
Absorbable Antibacterial Soft Tissue Support in Breast Reconstruction with Infection Outcomes Assessment - ARIA Trial
Principal Investigator
Brett T. Phillips, MD
Microvascular Surgeon
Protocol Number
IRB: PRO00119820
NCT: NCT06027996
Phase
Phase N/A
ClinicalTrials.gov
Enrollment Status
Open for Enrollment Soon
Support Duke Health research or honor a loved one with a tribute gift.
Giving to Duke Health